INTELLIGENT BIO SOLUTIONS INC.
ibs.incAI Executive Summary
AI-powered analysis of 10-Q filing content
Intelligent Bio Solutions shows severe financial distress with massive losses, deteriorating cash position, and concerning asset impairments. A 1-for-10 reverse stock split indicates significant market pressure, while the large subscription receivable suggests desperate capital raising efforts.
Red Flags Detected (7)
1-for-10 reverse stock split executed December 15, 2025 indicating severe stock price decline
Cash dropped 27% from $1.02M to $740K in 6 months with massive operating losses
$288,927 impairment of long-lived assets suggesting business model challenges
4 more red flags detected
Key Takeaways
Revenue growth of 36% to $2.0M is vastly overshadowed by 7x operating expense ratio
Emergency capital raising through subscription receivable suggests immediate liquidity needs
2 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.